Approved Technologies

The SAFETY Act provides two levels of liability protections for approval: Designation and Certification. By obtaining either Designation or Certification, companies obtain a level of legal protection in case their technology is ever put to use during a terrorist attack. See below for a list of approved technology certifications.

Company/Technology
Meridian Medical Technologies, Inc. Approved: September 27, 2016 | Expires: October 31, 2021 Meridian Medical Technologies, Inc. provides ATNAA, Diazepam, DuoDote®, Pralidoxime Chloride, AtroPen®, Morphine Auto-injectors (the “Technology”). The Technology is a series of ready-to-use, pre-filled auto-injectors intended for the treatment of chemical nerve agent exposure or for the management of pain. The Technology is approved for use by the U.S. Food and Drug Administration (“FDA”). It also includes packaging, stockpile storage of sterile auto-injector assemblies, stockpile storage of medical solutions, training auto-injectors, and the associated use protocols, labeling, and package inserts.
Meridian Medical Technologies, Inc.: AtroPen® Approved: November 09, 2006 | Expires: November 30, 2011 Meridian Medical Technologies, Inc., provides AtroPen®, a atropine auto-injector for the treatment of chemical nerve agent exposure.